Study of a new cannabinoid for long-term body pain
Treatments studied
Part of Pain clinical trials.
This Phase 2 study tests how a new cannabinoid product affects people with ongoing musculoskeletal pain (like arthritis or injuries). It’s meant to see whether the product can improve pain for eligible adults who are not already using CBD regularly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 21 years old and can give informed consent
- You can read and speak English fluently
- You have long-term pain from muscles, joints, or related problems (not cancer or mainly nerve pain)
- You do not currently use CBD products regularly
- You do not have a serious or unstable illness (especially major heart, liver, kidney, or seizure-related conditions)
- If you’ve had a significant head injury with loss of consciousness over 5 minutes, you may not qualify
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early study tests whether CBD can reduce symptoms of chronic pain in people receiving opioid maintenance treatment for opioid use disorder. It also looks at safety and whether CBD can be added without causing major problems.
This study tests whether a combination of THC and CBD can help people who have both opioid use disorder and chronic low back pain. You would need to be on a stable dose of methadone and have used cannabis at least once in your life.
This trial tests a full-spectrum cannabis extract (a product containing many cannabis compounds) to see if it helps with chronic pain and affects bone health in women. You will receive either the cannabis extract or a placebo (a dummy pill) in a random order, and neither you nor the study team will know which one you are taking at the time.
This trial tests a new cannabis-based product to see if it helps with gynecologic pain (like endometriosis). It looks at how the product works and whether it is safe and effective.
This Phase 2 study tests cannabidiol (CBD) to calm inflammation in the brain that may be linked to chronic low back pain. If you qualify, you’ll take study CBD and undergo brain imaging to see whether inflammation changes.
This study tests whether a new cannabinoid product can help with pain caused by endometriosis. It's for people who have at least moderate pain and are not currently using cannabis or similar products.
Hear when a new Chronic pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.